We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.32%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTA icon
1851
Enanta Pharmaceuticals
ENTA
$402M
$2.37M ﹤0.01%
+50,160
New +$2.72M
NESR
1852
National Energy Services Reunited Corp
NESR
$3.61B
$2.37M ﹤0.01%
+349,527
New +$2.54M
URBN icon
1853
Urban Outfitters
URBN
$6.81B
$2.37M ﹤0.01%
126,833
-487,851
-79% -$11.1M
EQRXW
1854
CALL
DELISTED
EQRx, Inc. Warrant
EQRXW
$2.36M ﹤0.01%
502,945
AVPTW
1855
CALL
DELISTED
AvePoint Inc Warrant
AVPTW
$2.36M ﹤0.01%
543,197
+28,406
+6% +$24K
GTHX
1856
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2.35M ﹤0.01%
476,822
+377,801
+382% +$2.09M
OTECW
1857
CALL
DELISTED
OceanTech Acquisitions I Corp. Warrant
OTECW
$2.35M ﹤0.01%
233,624
SOAR icon
1858
Volato Group
SOAR
$9.08M
$2.35M ﹤0.01%
9,518
+4
+0% +$990
MLNK
1859
DELISTED
MeridianLink
MLNK
$2.35M ﹤0.01%
140,618
+1,266
+0.9% +$21.8K
HXL icon
1860
Hexcel
HXL
$7.63B
$2.34M ﹤0.01%
+44,764
New +$2.46M
AI icon
1861
C3.ai
AI
$1.62B
$2.33M ﹤0.01%
+127,922
New +$2.35M
LEGAW
1862
CALL
DELISTED
Lead Edge Growth Opportunities, Ltd Warrant
LEGAW
$2.33M ﹤0.01%
237,493
APA icon
1863
APA Corp
APA
$14.4B
$2.33M ﹤0.01%
66,727
-63,072
-49% -$2.68M
PLBY icon
1864
Playboy Inc
PLBY
$136M
$2.33M ﹤0.01%
363,632
-61,007
-14% -$559K
ACAQ.WS
1865
CALL
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
$2.32M ﹤0.01%
231,619
ASCB
1866
DELISTED
A SPAC II Acquisition Corp. Ordinary Shares
ASCB
$2.3M ﹤0.01%
+233,400
New +$2.3M
SSAAW
1867
CALL
DELISTED
Science Strategic Acquisition Corp. Alpha Warrant
SSAAW
$2.29M ﹤0.01%
233,221
KNDI
1868
Kandi Technologies Group
KNDI
$63.1M
$2.29M ﹤0.01%
952,339
-417,248
-30% -$1.08M
EPWR.WS
1869
CALL
DELISTED
Empowerment & Inclusion Capital I Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
EPWR.WS
$2.29M ﹤0.01%
232,211
MIR.WS
1870
CALL
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$2.28M ﹤0.01%
395,905
+135,386
+52% +$199K
LITTW
1871
CALL
DELISTED
Logistics Innovation Technologies Corp. Warrant
LITTW
$2.28M ﹤0.01%
234,497
+151,167
+181% +$40.5K
CITEW
1872
CALL
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$2.28M ﹤0.01%
227,414
GTLS
1873
DELISTED
Chart Industries
GTLS
$2.27M ﹤0.01%
13,585
-26,539
-66% -$4.53M
SLVM icon
1874
Sylvamo
SLVM
$1.6B
$2.26M ﹤0.01%
+69,269
New +$2.91M
OKE icon
1875
Oneok
OKE
$56.9B
$2.26M ﹤0.01%
40,664
-13,140
-24% -$852K

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.